Novo Nordisk: Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors

NEXT STORY
Elemental Formula Sales Surge with Growing Shift to Hypoallergenic Solutions, finds Fact.MR Study
PREV STORY
HealthLynked Prepares For Future UpListing to the NASDAQ Capital Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019

author_avatar
NASDAQ Market News

NewLink Genetics Awarded $21.6 Million Contract Option by BARDA for Ebola Vaccine Development

AMES, Iowa, April 25, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

The global antimicrobial medical device coatings market by revenue is expected to grow at a CAGR of over 7% during the period 2021–2026

author_avatar
NASDAQ Market News